| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Cancer Research and Treatment Search > Browse Articles > Search



CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
Dae-Won Lee, Seock-Ah Im, Yu Jung Kim, Yaewon Yang, Jiyoung Rhee, Im Il Na, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, In Sil Choi, Do-Youn Oh, Jee Hyun Kim, Tae-You Kim, Yung-Jue Bang
Cancer Res Treat. 2017;49(3):807-815.   Published online January 18, 2017    DOI: https://doi.org/10.4143/crt.2016.326
                           Web of Science 6  Crossref 6
The Significance of Serum CA 19 - 9 Level in Gastric Adenocarcinoma
Yong Jin Kim, Byung Sik Kim, Jeong Hwan Yook, Sung Tae Oh, Byung Sun Suh, Wan Soo Kim, Yong Ho Kim, Kun Chun Park
J Korean Cancer Assoc. 2000;32(1):38-43.
      
The Significance of Serum CA 19-9 Level Change after Biliary Drainage Procedures in Pancreatic and Biliary Tract Cancer
Hyun Kag Kim, Chang Hee Lee, Baek Yeol Ryoo, Sook Hyang Jung, You Cheoul Kim, Chang Min Kim, Jhin Oh Lee, Taik Koo Yun, Young Soo Do, Byung Hee Lee
J Korean Cancer Assoc. 1995;27(6):929-936.
      
Korean Cancer Association
E-Submission
EndNote Output Style
Email Alert
Journal Impact Factor 4.6
SCImago Journal & Country Rank
PubMed Central
MEDLINE/PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association.                 Developed in M2PI